TY - JOUR
T1 - Kinetic studies of FR-1, a growth factor-inducible aldo-keto reductase
AU - Srivastava, Sanjay
AU - Harter, Theresa M.
AU - Chandra, Animesh
AU - Bhatnagar, Aruni
AU - Srivastava, Satish K.
AU - Petrash, J. Mark
PY - 1998/9/15
Y1 - 1998/9/15
N2 - Murine fibroblasts cultured in the presence of fibroblast growth factor- 1 express relatively high levels of FR-1, a ~36 kDa protein related to the aldo-keto reductase superfamily [Donohue, P. J., Alberts, G. F., Hampton, B. S., Winkles, J. A. (1994) J. BioI. Chem. 269, 8604-8609]. While the crystal structure of FR-I shows striking homology with human aldose reductase [Wilson, D. K., Nakano, T., Petrash, J. M., Quiocho, F. A. (1995) Biochemistry, 34, 14323-14330], an enzyme linked to the pathogenesis of diabetic complications, the physiological role of FR-1 is not known. We show that FR-1 is capable of reducing a broad range of aromatic and aliphatic aldehydes, including the abundant and highly reactive lipid-derived aldehyde 4-hydroxy-2-nonenal (HNE; K(m) ≃ 9 μM). However, in the absence of coenzyme, HNE caused a time-dependent inactivation of FR-1. Results from electrospray ionization-mass spectrometry and Edman-degradation of peptides derived from HNE-modified FR-1 were consistent with formation of a Michael adduct at Cys298. This was confirmed with a C298S mutant, which was resistant to HNE-induced inactivation. Since steady-state K(m) values determined with alkanals, α,β-unsaturated alkenals, alkadienals, and 4-hydroxyalkenals fall within their physiological concentrations, lipid-derived aldehydes appear to be potential in vivo substrates for FR-1.
AB - Murine fibroblasts cultured in the presence of fibroblast growth factor- 1 express relatively high levels of FR-1, a ~36 kDa protein related to the aldo-keto reductase superfamily [Donohue, P. J., Alberts, G. F., Hampton, B. S., Winkles, J. A. (1994) J. BioI. Chem. 269, 8604-8609]. While the crystal structure of FR-I shows striking homology with human aldose reductase [Wilson, D. K., Nakano, T., Petrash, J. M., Quiocho, F. A. (1995) Biochemistry, 34, 14323-14330], an enzyme linked to the pathogenesis of diabetic complications, the physiological role of FR-1 is not known. We show that FR-1 is capable of reducing a broad range of aromatic and aliphatic aldehydes, including the abundant and highly reactive lipid-derived aldehyde 4-hydroxy-2-nonenal (HNE; K(m) ≃ 9 μM). However, in the absence of coenzyme, HNE caused a time-dependent inactivation of FR-1. Results from electrospray ionization-mass spectrometry and Edman-degradation of peptides derived from HNE-modified FR-1 were consistent with formation of a Michael adduct at Cys298. This was confirmed with a C298S mutant, which was resistant to HNE-induced inactivation. Since steady-state K(m) values determined with alkanals, α,β-unsaturated alkenals, alkadienals, and 4-hydroxyalkenals fall within their physiological concentrations, lipid-derived aldehydes appear to be potential in vivo substrates for FR-1.
UR - http://www.scopus.com/inward/record.url?scp=0032531045&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032531045&partnerID=8YFLogxK
U2 - 10.1021/bi9804333
DO - 10.1021/bi9804333
M3 - Article
C2 - 9737870
AN - SCOPUS:0032531045
SN - 0006-2960
VL - 37
SP - 12909
EP - 12917
JO - Biochemistry
JF - Biochemistry
IS - 37
ER -